• Mutation; HGNC; 6190; JAK1; Simple; p.Gly1097Val (c.3290_3291delinsTT); Zygosity=Unspecified (PubMed=28356514).
  
• Mutation; HGNC; 11364; STAT3; Simple; p.Gly618Arg (c.1852G>C); ClinVar=VCV001192236; Zygosity=Unspecified (PubMed=28356514).
  

PubMed=8035614
Del Mistro A., Leszl A., Bertorelle R., Calabro M.L., Panozzo M., Menin C., D'Andrea E., Chieco-Bianchi L.
A CD30-positive T cell line established from an aggressive anaplastic large cell lymphoma, originally diagnosed as Hodgkin's disease.
Leukemia 8:1214-1219(1994)

PubMed=8558920
Dirks W.G., Zaborski M., Jager K., Challier C., Shiota M., Quentmeier H., Drexler H.G.
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Leukemia 10:142-149(1996)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=15356658; DOI=10.1038/sj.leu.2403465
Drexler H.G., MacLeod R.A.F.
Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma.
Leukemia 18:1569-1571(2004)

PubMed=16596703; DOI=10.1002/pmic.200500647
Cussac D., Pichereaux C., Colomba A., Capilla F., Pont F., Gaits-Iacovoni F., Lamant L., Espinos E., Burlet-Schiltz O., Monsarrat B., Delsol G., Payrastre B.
Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers.
Proteomics 6:3210-3222(2006)

PubMed=26657151; DOI=10.1038/onc.2015.456; PMCID=PMC4907875
Ceccon M., Merlo M.E.B., Mologni L., Poggio T., Varesio L.M., Menotti M., Bombelli S., Rigolio R., Manazza A.D., Di Giacomo F., Ambrogio C., Giudici G., Casati C., Mastini C., Compagno M., Turner S.D., Gambacorti-Passerini C., Chiarle R., Voena C.
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.
Oncogene 35:3854-3865(2016)

PubMed=28356514; DOI=10.1073/pnas.1700682114; PMCID=PMC5393253
Chen J., Zhang Y., Petrus M.N., Xiao W.-M., Nicolae A., Raffeld M., Pittaluga S., Bamford R.N., Nakagawa M., Ouyang S.T.-Y., Epstein A.L., Kadin M.E., Del Mistro A., Woessner R.D., Jaffe E.S., Waldmann T.A.
Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Proc. Natl. Acad. Sci. U.S.A. 114:3975-3980(2017)

PubMed=29533902; DOI=10.1515/hsz-2017-0321
Drexler H.G., Pommerenke C., Eberth S., Nagel S.
Hodgkin lymphoma cell lines: to separate the wheat from the chaff.
Biol. Chem. 399:511-523(2018)